Co-Diagnostics, Inc. to Present at 14th Next Generation Dx Summit in Washington, D.C.

Rhea-AI Summary

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) is set to sponsor, present, and host a booth at the 14th Annual Next Generation Dx Summit from August 22-24 in Washington, D.C.. The summit focuses on advancements in point-of-care, infectious disease, and liquid biopsy diagnostics. CEO Dwight Egan will present the upcoming Co-Dx PCR Home platform on August 22 at 12:15 PM ET. In-person attendees can visit the Company at Booth #206. For more details on the summit, visit Next Generation Dx.

SALT LAKE CITY, Aug. 22, 2022 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be sponsoring, presenting and hosting a booth this week at the 14^th Annual Next Generation Dx Summit, held virtually and in-person in Washington, D.C. on August 22-24.

The Next Generation Dx Summit offers a valuable window into how point-of-care, infectious disease, liquid biopsy and companion diagnostics are changing the standard of care, and includes three streams: Point-of-Care and Infectious Disease, Companion Diagnostics and Reimbursement stream, and Liquid Biopsy and Early Detection. On Monday, August 22, at 12:15 PM ET, Company CEO Dwight Egan will be presenting on the Company's forthcoming Co-Dx PCR Home platform, in the conference's Enabling Point-of-Care diagnostics program.

In-person visitors are invited to visit the Company at Booth #206.

To learn more about the summit, including in-person and virtual registration details, please visit https://www.nextgenerationdx.com.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-present-at-14th-next-generation-dx-summit-in-washington-dc-301609998.html

SOURCE Co-Diagnostics

FAQ

What is the date of the Next Generation Dx Summit that CODX will attend?

The Next Generation Dx Summit is from August 22-24, 2022.

Where is Co-Diagnostics sponsoring the Next Generation Dx Summit?

Co-Diagnostics is sponsoring the summit in Washington, D.C.

Who will present at the summit for CODX?

CEO Dwight Egan will present for Co-Diagnostics.

What will CODX present at the summit?

Co-Diagnostics will present the Co-Dx PCR Home platform.

What time is CODX's presentation at the summit?

The presentation is scheduled for August 22 at 12:15 PM ET.

Where can attendees find Co-Diagnostics at the summit?

Attendees can visit Co-Diagnostics at Booth #206.